DOI:
10.1055/s-00000088
TumorDiagnostik & Therapie
LinksClose Window
References
Zukotynski K, Yap JT, Giobbie-Hurder A. et al.
Metabolic response by FDG-PET to imatinib correlates with exon 11 KIT mutation and predicts outcome in patients with mucosal melanoma.
Cancer Imaging 2014;
14: 30
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.